Eli Lilly & Co. (LLY:US) had the second-steepest retreat in the S&P 500, losing 3.9 percent to $35.13. The maker of the antipsychotic Zyprexa said 2009 profit excluding some costs probably won’t exceed $4.40 a share. Analysts polled by Bloomberg estimated $4.42 per share on average.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.